The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia
Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP. The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quanti...
Gespeichert in:
Veröffentlicht in: | PloS one 2015-01, Vol.10 (1), p.e0117704-e0117704 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0117704 |
---|---|
container_issue | 1 |
container_start_page | e0117704 |
container_title | PloS one |
container_volume | 10 |
creator | Ye, Xin Zhang, Lei Wang, Hui Chen, Yan Zhang, Weiwei Zhu, Rongrong Fang, Chaoping Deng, Anmei Qian, Baohua |
description | Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.
The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.
The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.
The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment. |
doi_str_mv | 10.1371/journal.pone.0117704 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1648300557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A421818189</galeid><doaj_id>oai_doaj_org_article_baca434ad5f44fb2aa015a7c96d38800</doaj_id><sourcerecordid>A421818189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-9fa4cf694aff91b09d5d3fae0433e2c37670ce14775030bc003ce30393c369593</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7jr6D0QLgujFzCbNR5sbYVn8GBgY0NHbcJom0yxtMzap6_57U6e7TGUvJBcNyXPek_P2TZKXGK0wyfHFtRv6DprVwXV6hTDOc0QfJedYkGzJM0Qen-zPkmfeXyPESMH50-QsYzzDVKDzZLurddq7RqfOpOvNMiMXuxrn6QFCfQO3qe3GrdVd8OmNDXV66G0Lfbxo26HTaah715ZO3QZ30J2F58kTA43XL6bvIvn-6ePu6stys_28vrrcLBUXWVgKA1QZLigYI3CJRMUqYkAjSojOFMl5jpTGNM8ZIqhUCBGlCSKCKMIFE2SRvD7qHhrn5eSFl5jTgsQ5WR6J9ZGoHFzL6dnSgZV_D1y_l9AHqxotS1BACYWKGUpNmQEgzCBXglekKGLvRfJh6jaUra5UtKOHZiY6v-lsLfful6QEccZGgXeTQO9-DtoH2VqvdNNAp90wvptlFGNRsIi--Qd9eLqJ2kMcwHbGxb5qFJWXNMPFuEaXVg9QcVW6tSoGx9h4Pit4PyuITNC_wx4G7-X629f_Z7c_5uzbE7bW0ITau2YI1nV-DtIjqHrnfa_NvckYyTH3d27IMfdyyn0se3X6g-6L7oJO_gAKpft1</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1648300557</pqid></control><display><type>article</type><title>The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Ye, Xin ; Zhang, Lei ; Wang, Hui ; Chen, Yan ; Zhang, Weiwei ; Zhu, Rongrong ; Fang, Chaoping ; Deng, Anmei ; Qian, Baohua</creator><contributor>Kuwana, Masataka</contributor><creatorcontrib>Ye, Xin ; Zhang, Lei ; Wang, Hui ; Chen, Yan ; Zhang, Weiwei ; Zhu, Rongrong ; Fang, Chaoping ; Deng, Anmei ; Qian, Baohua ; Kuwana, Masataka</creatorcontrib><description>Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.
The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.
The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.
The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0117704</identifier><identifier>PMID: 25621490</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Aged ; Analysis ; Antigens ; Arthritis ; Autoimmune diseases ; Bleeding ; Care and treatment ; Case-Control Studies ; Cells, Cultured ; Correlation ; Cytokines ; Cytometry ; Development and progression ; Dexamethasone - therapeutic use ; Drug dosages ; Enzyme-linked immunosorbent assay ; Etiology ; Female ; Flow cytometry ; Gene Expression ; Glucocorticoids - therapeutic use ; Helper cells ; Hospitals ; Humans ; Idiopathic thrombocytopenic purpura ; Interleukin 12 ; Interleukin 17 ; Interleukin 23 ; Interleukin-17 - blood ; Interleukin-17 - genetics ; Interleukin-23 - blood ; Interleukin-23 - genetics ; Laboratories ; Lymphocytes ; Lymphocytes T ; Male ; Middle Aged ; Pathogenesis ; Patients ; Pediatrics ; Platelet Count ; Platelets ; Purpura, Thrombocytopenic, Idiopathic - blood ; Purpura, Thrombocytopenic, Idiopathic - drug therapy ; Purpura, Thrombocytopenic, Idiopathic - immunology ; Receptors ; RNA ; Stimulation ; Studies ; Systemic lupus erythematosus ; Th17 Cells - physiology ; Thrombocytopenia ; Young Adult</subject><ispartof>PloS one, 2015-01, Vol.10 (1), p.e0117704-e0117704</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Ye et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Ye et al 2015 Ye et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-9fa4cf694aff91b09d5d3fae0433e2c37670ce14775030bc003ce30393c369593</citedby><cites>FETCH-LOGICAL-c692t-9fa4cf694aff91b09d5d3fae0433e2c37670ce14775030bc003ce30393c369593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306550/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306550/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25621490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kuwana, Masataka</contributor><creatorcontrib>Ye, Xin</creatorcontrib><creatorcontrib>Zhang, Lei</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Zhang, Weiwei</creatorcontrib><creatorcontrib>Zhu, Rongrong</creatorcontrib><creatorcontrib>Fang, Chaoping</creatorcontrib><creatorcontrib>Deng, Anmei</creatorcontrib><creatorcontrib>Qian, Baohua</creatorcontrib><title>The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.
The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.
The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.
The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Antigens</subject><subject>Arthritis</subject><subject>Autoimmune diseases</subject><subject>Bleeding</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Cells, Cultured</subject><subject>Correlation</subject><subject>Cytokines</subject><subject>Cytometry</subject><subject>Development and progression</subject><subject>Dexamethasone - therapeutic use</subject><subject>Drug dosages</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Etiology</subject><subject>Female</subject><subject>Flow cytometry</subject><subject>Gene Expression</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Helper cells</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Idiopathic thrombocytopenic purpura</subject><subject>Interleukin 12</subject><subject>Interleukin 17</subject><subject>Interleukin 23</subject><subject>Interleukin-17 - blood</subject><subject>Interleukin-17 - genetics</subject><subject>Interleukin-23 - blood</subject><subject>Interleukin-23 - genetics</subject><subject>Laboratories</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Platelet Count</subject><subject>Platelets</subject><subject>Purpura, Thrombocytopenic, Idiopathic - blood</subject><subject>Purpura, Thrombocytopenic, Idiopathic - drug therapy</subject><subject>Purpura, Thrombocytopenic, Idiopathic - immunology</subject><subject>Receptors</subject><subject>RNA</subject><subject>Stimulation</subject><subject>Studies</subject><subject>Systemic lupus erythematosus</subject><subject>Th17 Cells - physiology</subject><subject>Thrombocytopenia</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAUhoso7jr6D0QLgujFzCbNR5sbYVn8GBgY0NHbcJom0yxtMzap6_57U6e7TGUvJBcNyXPek_P2TZKXGK0wyfHFtRv6DprVwXV6hTDOc0QfJedYkGzJM0Qen-zPkmfeXyPESMH50-QsYzzDVKDzZLurddq7RqfOpOvNMiMXuxrn6QFCfQO3qe3GrdVd8OmNDXV66G0Lfbxo26HTaah715ZO3QZ30J2F58kTA43XL6bvIvn-6ePu6stys_28vrrcLBUXWVgKA1QZLigYI3CJRMUqYkAjSojOFMl5jpTGNM8ZIqhUCBGlCSKCKMIFE2SRvD7qHhrn5eSFl5jTgsQ5WR6J9ZGoHFzL6dnSgZV_D1y_l9AHqxotS1BACYWKGUpNmQEgzCBXglekKGLvRfJh6jaUra5UtKOHZiY6v-lsLfful6QEccZGgXeTQO9-DtoH2VqvdNNAp90wvptlFGNRsIi--Qd9eLqJ2kMcwHbGxb5qFJWXNMPFuEaXVg9QcVW6tSoGx9h4Pit4PyuITNC_wx4G7-X629f_Z7c_5uzbE7bW0ITau2YI1nV-DtIjqHrnfa_NvckYyTH3d27IMfdyyn0se3X6g-6L7oJO_gAKpft1</recordid><startdate>20150126</startdate><enddate>20150126</enddate><creator>Ye, Xin</creator><creator>Zhang, Lei</creator><creator>Wang, Hui</creator><creator>Chen, Yan</creator><creator>Zhang, Weiwei</creator><creator>Zhu, Rongrong</creator><creator>Fang, Chaoping</creator><creator>Deng, Anmei</creator><creator>Qian, Baohua</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150126</creationdate><title>The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia</title><author>Ye, Xin ; Zhang, Lei ; Wang, Hui ; Chen, Yan ; Zhang, Weiwei ; Zhu, Rongrong ; Fang, Chaoping ; Deng, Anmei ; Qian, Baohua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-9fa4cf694aff91b09d5d3fae0433e2c37670ce14775030bc003ce30393c369593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Antigens</topic><topic>Arthritis</topic><topic>Autoimmune diseases</topic><topic>Bleeding</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Cells, Cultured</topic><topic>Correlation</topic><topic>Cytokines</topic><topic>Cytometry</topic><topic>Development and progression</topic><topic>Dexamethasone - therapeutic use</topic><topic>Drug dosages</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Etiology</topic><topic>Female</topic><topic>Flow cytometry</topic><topic>Gene Expression</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Helper cells</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Idiopathic thrombocytopenic purpura</topic><topic>Interleukin 12</topic><topic>Interleukin 17</topic><topic>Interleukin 23</topic><topic>Interleukin-17 - blood</topic><topic>Interleukin-17 - genetics</topic><topic>Interleukin-23 - blood</topic><topic>Interleukin-23 - genetics</topic><topic>Laboratories</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Platelet Count</topic><topic>Platelets</topic><topic>Purpura, Thrombocytopenic, Idiopathic - blood</topic><topic>Purpura, Thrombocytopenic, Idiopathic - drug therapy</topic><topic>Purpura, Thrombocytopenic, Idiopathic - immunology</topic><topic>Receptors</topic><topic>RNA</topic><topic>Stimulation</topic><topic>Studies</topic><topic>Systemic lupus erythematosus</topic><topic>Th17 Cells - physiology</topic><topic>Thrombocytopenia</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ye, Xin</creatorcontrib><creatorcontrib>Zhang, Lei</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Zhang, Weiwei</creatorcontrib><creatorcontrib>Zhu, Rongrong</creatorcontrib><creatorcontrib>Fang, Chaoping</creatorcontrib><creatorcontrib>Deng, Anmei</creatorcontrib><creatorcontrib>Qian, Baohua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Xin</au><au>Zhang, Lei</au><au>Wang, Hui</au><au>Chen, Yan</au><au>Zhang, Weiwei</au><au>Zhu, Rongrong</au><au>Fang, Chaoping</au><au>Deng, Anmei</au><au>Qian, Baohua</au><au>Kuwana, Masataka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-01-26</date><risdate>2015</risdate><volume>10</volume><issue>1</issue><spage>e0117704</spage><epage>e0117704</epage><pages>e0117704-e0117704</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.
The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.
The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.
The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25621490</pmid><doi>10.1371/journal.pone.0117704</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2015-01, Vol.10 (1), p.e0117704-e0117704 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1648300557 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Adolescent Adult Aged Analysis Antigens Arthritis Autoimmune diseases Bleeding Care and treatment Case-Control Studies Cells, Cultured Correlation Cytokines Cytometry Development and progression Dexamethasone - therapeutic use Drug dosages Enzyme-linked immunosorbent assay Etiology Female Flow cytometry Gene Expression Glucocorticoids - therapeutic use Helper cells Hospitals Humans Idiopathic thrombocytopenic purpura Interleukin 12 Interleukin 17 Interleukin 23 Interleukin-17 - blood Interleukin-17 - genetics Interleukin-23 - blood Interleukin-23 - genetics Laboratories Lymphocytes Lymphocytes T Male Middle Aged Pathogenesis Patients Pediatrics Platelet Count Platelets Purpura, Thrombocytopenic, Idiopathic - blood Purpura, Thrombocytopenic, Idiopathic - drug therapy Purpura, Thrombocytopenic, Idiopathic - immunology Receptors RNA Stimulation Studies Systemic lupus erythematosus Th17 Cells - physiology Thrombocytopenia Young Adult |
title | The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A36%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20IL-23/Th17%20pathway%20in%20patients%20with%20primary%20immune%20thrombocytopenia&rft.jtitle=PloS%20one&rft.au=Ye,%20Xin&rft.date=2015-01-26&rft.volume=10&rft.issue=1&rft.spage=e0117704&rft.epage=e0117704&rft.pages=e0117704-e0117704&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0117704&rft_dat=%3Cgale_plos_%3EA421818189%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1648300557&rft_id=info:pmid/25621490&rft_galeid=A421818189&rft_doaj_id=oai_doaj_org_article_baca434ad5f44fb2aa015a7c96d38800&rfr_iscdi=true |